Galena Biopharma Inc. (GALE)

5.72
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 5.72
Open 5.72
Day Low/High 5.56 / 5.85
52 Wk Low/High 3.43 / 19.80
Volume 55.42K
Avg Volume 886.60K
Exchange NASDAQ
Shares Outstanding 45.71M
Market Cap 11.98M
EPS -2,128.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Hagens Berman Investigating Galena Biopharma And CytRx Corporation For Securities Fraud; Notifies Investors Of Deadlines

Hagens Berman Investigating Galena Biopharma And CytRx Corporation For Securities Fraud; Notifies Investors Of Deadlines

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Galena Biopharma, Inc.

Today's Dead Cat Bounce Stock Is Galena Biopharma (GALE)

Today's Dead Cat Bounce Stock Is Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Galena Biopharma was a leading decliner within the health care sector, falling $0.40 (-12.4%) to $2.82 on heavy volume

Galena Biopharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Galena Biopharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action...

Galena Discloses SEC Investigation Focused on Stock-Touting Campaign

Galena Discloses SEC Investigation Focused on Stock-Touting Campaign

The SEC investigation into Galena began in February, following an exclusive story by TheStreet.

Investors deserve answers from galena and cytrx about involvement in stock promo

Investors deserve answers from galena and cytrx about involvement in stock promo

Richard Pearson's expose, published yesterday on Seeking Alpha, pulls back the curtain on the shady world of paid stock touts. It's an excellent, well-researched story, mostly because of the documentation (emails and electronic signatures) Pearson obtained linking executives at Cytrx and Galena Biopharma to the publication of promotional articles under assumed names and without proper financial disclosure.

Wolf Haldenstein Announces Investigation Of Galena Biopharma, Inc.

Wolf Haldenstein Announces Investigation Of Galena Biopharma, Inc.

The law firm of Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating potential federal securities claims against Galena Biopharma, Inc.

Galena Biopharma Launches Galena Patient Services (GPS)

Galena Biopharma Launches Galena Patient Services (GPS)

Galena Patient Services (GPS) is a Full-Service Program to Help Manage Access and Reimbursement for Patients Taking Abstral(R) (fentanyl) Sublingual Tablets

Galena Biopharma Inc (GALE): Today's Featured Drugs Winner

Galena Biopharma Inc (GALE): Today's Featured Drugs Winner

Galena Biopharma was a winner within the drugs industry, rising $0.10 (2.6%) to $3.95 on average volume

GALENA SHAREHOLDERS NOTICE: Johnson & Weaver, LLP Is Investigating Whether Galena Biopharma, Inc. Insiders Promoted And Then Unloaded Stock

GALENA SHAREHOLDERS NOTICE: Johnson & Weaver, LLP Is Investigating Whether Galena Biopharma, Inc. Insiders Promoted And Then Unloaded Stock

Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Galena Biopharma, Inc.

Biotech Stock 'Hate' Mailbag: Readers Riot Over Galena, Prana

Biotech Stock 'Hate' Mailbag: Readers Riot Over Galena, Prana

I've received so much hate email and tweets over the past week, enough to fill a special edition of the Mailbag.

Galena Biopharma (GALE) Is Today's Dead Cat Bounce Stock

Galena Biopharma (GALE) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

Jim Cramer's 'Mad Money' CEO Chats: Edwards Lifesciences and Galena Biopharma

Jim Cramer's 'Mad Money' CEO Chats: Edwards Lifesciences and Galena Biopharma

Jim Cramer talks to the CEOs of two companies representing the big and small sides of health care in America.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation Of GALENA BIOPHARMA, INC. For Possible Breaches Of Fiduciary Duty

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation Of GALENA BIOPHARMA, INC. For Possible Breaches Of Fiduciary Duty

Levi & Korsinsky is investigating Galena Biopharma, Inc. (“Galena Biopharma” or the “Company”) (Nasdaq:GALE) for possible breaches of fiduciary duty.

The Rosen Law Firm Announces Investigation Of Securities Claims Against Galena Biopharma, Inc. – GALE

The Rosen Law Firm Announces Investigation Of Securities Claims Against Galena Biopharma, Inc. – GALE

The Rosen Law Firm announces that it is investigating potential securities fraud claims against Galena Biopharma, Inc.

Galena CEO's Response to Stock Promotions Leaves Questions Unanswered

Galena CEO's Response to Stock Promotions Leaves Questions Unanswered

A new document shows how Galena's marketing firm, The DreamTeam Group, ghost-writes articles for Seeking Alpha without disclosure.

Galena Biopharma Pays For Stock-Touting Campaign While Insiders Cash Out Millions

Galena Biopharma Pays For Stock-Touting Campaign While Insiders Cash Out Millions

Seeking Alpha removes articles after finding single author used multiple aliases to promote Galena.

Water-Logged And Getting Wetter Stock Of The Day: Galena Biopharma (GALE)

Water-Logged And Getting Wetter Stock Of The Day: Galena Biopharma (GALE)

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Galena Biopharma was a leading decliner within the health care sector, falling $0.20 (-3.7%) to $5.19 on light volume

Galena Biopharma (GALE) In A Perilous Reversal

Galena Biopharma (GALE) In A Perilous Reversal

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate

Galena CEO, Seeking Alpha and the Art of the Interview Dodge

Galena CEO, Seeking Alpha and the Art of the Interview Dodge

When amateur fanboy investors interview CEOs, the questions are lobbed softballs and the responses easily deflect away from the real issues.

Galena Biopharma (GALE) Showing Signs Of A Dead Cat Bounce Today

Galena Biopharma (GALE) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

Insider Trading Alert - WNR, GALE, AOS, ALXN And IBKR Traded By Insiders

Insider Trading Alert - WNR, GALE, AOS, ALXN And IBKR Traded By Insiders

Stocks with insider trader activity include WNR, GALE, AOS, ALXN and IBKR